Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC, Immunotherapy

Suresh Ramalingam

MD

🏢Emory University🌐USA

Executive Director, Winship Cancer Institute

87
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Suresh Ramalingam is a leading thoracic oncologist and translational researcher who directs the Winship Cancer Institute at Emory. He has been a key investigator in multiple squamous NSCLC trials and is particularly noted for his work on combination immunotherapy strategies and his leadership of the FLAURA2 trial. He contributes to squamous-specific treatment algorithm development.

Share:

🧪Research Fields 研究领域

squamous NSCLC IO combinations
osimertinib FLAURA2
NSCLC combination immunotherapy
EGFR NSCLC
thoracic oncology clinical research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Suresh Ramalingam 的研究动态

Follow Suresh Ramalingam's research updates

留下邮箱,当我们发布与 Suresh Ramalingam(Emory University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment